Literature DB >> 6339220

Historical and modern epidemiological studies on populations exposed to N-substituted aryl compounds.

R A Cartwright.   

Abstract

The historical exposures to aromatic amines of various occupational groups are briefly reviewed. Modern studies indicate that other occupational groups might have risks worth investigating; these include machinists and workers in the chemical industry. Details of a recent investigation into the exposure of dye workers are given which indicate a lowered risk in recent years since the introduction of safety measures. Nonoccupational exposures to the aromatic amines are also discussed. They include cigarette smoking and phenacetin abuse, the former being a potent causal agent in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339220      PMCID: PMC1569142          DOI: 10.1289/ehp.834913

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  26 in total

1.  CHLORNAPHAZIN (ERYSAN) MAY INDUCE CANCER OF THE URINARY BLADDER.

Authors:  A VIDEBAEK
Journal:  Acta Med Scand       Date:  1964-07

2.  CHLORNAPHAZINE AS A BLADDER CARCINOGEN.

Authors:  T THIEDE; E CHIEVITZ; B C CHRISTENSEN
Journal:  Acta Med Scand       Date:  1964-06

3.  AN EPIDEMIOLOGICAL INVESTIGATION OF CANCER OF THE BLADDER.

Authors:  E L WYNDER; J ONDERDONK; N MANTEL
Journal:  Cancer       Date:  1963-11       Impact factor: 6.860

4.  MORTALITY OF GASWORKERS WITH SPECIAL REFERENCE TO CANCERS OF THE LUNG AND BLADDER, CHRONIC BRONCHITIS, AND PNEUMOCONIOSIS.

Authors:  R DOLL; R E FISHER; E J GAMMON; W GUNN; G O HUGHES; F H TYRER; W WILSON
Journal:  Br J Ind Med       Date:  1965-01

5.  BLADDER TUMOURS IN THE ELECTRIC-CABLE INDUSTRY.

Authors:  J M DAVIES
Journal:  Lancet       Date:  1965-07-24       Impact factor: 79.321

6.  The first reported cases of human bladder tumors due to a new carcinogen-xenylamine.

Authors:  W F MELICK; H M ESCUE; J J NARYKA; R A MEZERA; E P WHEELER
Journal:  J Urol       Date:  1955-12       Impact factor: 7.450

7.  [Etiology and prophylaxis of occupational tumors in dye workers].

Authors:  F UEBELIN; A PLETSCHER
Journal:  Schweiz Med Wochenschr       Date:  1954-08-07

8.  Bladder tumors in a coal tar dye plant.

Authors:  L J Goldwater; A J Rosso; M Kleinfeld
Journal:  Arch Environ Health       Date:  1965-12

9.  Cohort study of workers exposed to betanaphthylamine and benzidine.

Authors:  T F Mancuso; A A el-Attar
Journal:  J Occup Med       Date:  1967-06

10.  Tumours of the urinary tract as an occupational disease in several industries.

Authors:  R A Case
Journal:  Ann R Coll Surg Engl       Date:  1966-10       Impact factor: 1.891

View more
  5 in total

1.  Application of zeolite-activated carbon macrocomposite for the adsorption of Acid Orange 7: isotherm, kinetic and thermodynamic studies.

Authors:  Chi Kim Lim; Hui Han Bay; Chin Hong Neoh; Azmi Aris; Zaiton Abdul Majid; Zaharah Ibrahim
Journal:  Environ Sci Pollut Res Int       Date:  2013-05-08       Impact factor: 4.223

Review 2.  Degradation of dyes from aqueous solution by Fenton processes: a review.

Authors:  Puthiya Veetil Nidheesh; Rajan Gandhimathi; Srikrishnaperumal Thanga Ramesh
Journal:  Environ Sci Pollut Res Int       Date:  2013-01-22       Impact factor: 4.223

3.  Quantification of haemoglobin binding of 4,4'-methylenebis(2-chloroaniline) (MOCA) in rats.

Authors:  G Sabbioni; H G Neumann
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

4.  Biosorption and biodegradation of Acid Orange 7 by Enterococcus faecalis strain ZL: optimization by response surface methodological approach.

Authors:  Chi Kim Lim; Hui Han Bay; Azmi Aris; Zaiton Abdul Majid; Zaharah Ibrahim
Journal:  Environ Sci Pollut Res Int       Date:  2013-01-20       Impact factor: 4.223

5.  Experimentally designed chemometric models for the assay of toxic adulterants in turmeric powder.

Authors:  Shymaa S Soliman; Alaadin E El-Haddad; Ghada A Sedik; Mohamed R Elghobashy; Hala E Zaazaa; Ahmed S Saad
Journal:  RSC Adv       Date:  2022-03-23       Impact factor: 3.361

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.